Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. - Koscielniak,E.; Klingebiel,T.H.; Peters,C.; Hermann,J.; Burdach,S.T.; Bender-Gotze,C.; Muller-Weihrich,S.T.; Treuner,J. (Bone Marrow Transplant, 1997)